CSI Market
Sign In | Register

Myokardia Inc (MYOK) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MYOK Annual Cash Flow →
The data below summarizes Myokardia Inc's cash flow activity from Sep 30 2019 to Sep 30 2020, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2020)
9 Months 		(Jun 30 2020) (Mar 31 2020) (Dec 31 2019) (Sep 30 2019)
Operating Activities
Income-218.20
Depreciation & amortization2.46
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.05
Share-based Compensation32.98
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Redeemable Convertible Preferred Stock Call Option Liability-
Prepayment From Collaboration Partner-
Increase Decrease In Operating Lease Right Of Use Assets2.57
Income Tax Benefit Of Unrealized Gains On Short And Long Term Investments-
Income Tax Benefit Of Unrealized Gains On Investments-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-1.32
Increase (Decrease) in Accrued Liabilities7.52
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-4.90
Other Working Capital-1.57
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities38.17
Discontinued operations0.00
Net Cash flow from Operating Activities-142.24
Investing Activities
Capital Expenditures-15.88
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Sales Of Investments4.00
Proceeds From Maturities Of Investments233.58
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments-128.89
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities92.81
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock605.06
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.63
Vesting Of Early Exercised Options And Restricted Stock-
Capital Expenditures Incurred But Not Yet Paid0.63
Unpaid Portion Of Property And Equipment Purchases Included In Accrued Liabilities-
Temporary Equity Dividends Adjustment-
Temporary Equity Accretion To Redemption Value Adjustment-
Proceeds From Payments For Issuance Initial Public Offering Net Of Issuance Costs-
Proceeds From Exercise Of Stock Options And Employee Stock Purchase Plan18.85
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities623.91
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-158.12
Total Cash Flow574.48
4 historic quarters locked

Sign in to unlock the full Myokardia Inc cash flow history.

Sign In Create Free Account

About MYOK Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.